Riskpilot← Back to searchSign inGet full accessNORDIC PHYTOTECH ApS
APSActiveCVR 35047557Korskildelund 4Wholesale of other food · NACE 4638Est. 20131 employees
Revenue 2025
DKK 287K
+2% vs 2024
EBITDA margin
82.5%
-16% vs 2024
Equity ratio
58.0%
Financial strength
Net profit 2025
DKK 175K
-26% vs 2024
| Revenue | DKK 287K | +2% |
| EBITDA | DKK 237K | -16% |
| Net profit | DKK 175K | -26% |
| Total assets | DKK 978K | +9% |
| Equity | DKK 567K | +44% |
| Employees | 1 | — |
Legal name
NORDIC PHYTOTECH ApS
CVR number
35047557
Legal form
Anpartsselskab
NACE code
4638 · Wholesale of other food
Founded
19. februar 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen i forening med en direktør.
Company purpose
Selskabets formål er at drive konsulentvirksomhed, at handle og udvikle kosttilskud og naturlægemidler samt at drive import og eksport forretning.
Address
Korskildelund 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -463 | -36 | 244 | 762 | 296 | 230 | 318 | 246 | 272 | 206 | -75 | 281 | 287 |
| Staff expenses | -0 | -0 | -0 | -200 | -242 | -182 | -182 | -183 | -206 | -183 | -46 | -0 | -50 |
| EBITDA | -463 | -36 | 244 | 562 | 54 | 48 | 135 | 63 | 66 | 22 | -121 | 281 | 237 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -463 | -36 | 244 | 562 | 54 | 48 | 135 | 63 | 66 | 22 | -121 | 281 | 237 |
| Net financials | -16 | -39 | -38 | -72 | -44 | -44 | -76 | -2 | -8 | -61 | -24 | -29 | -13 |
| Profit before tax | -479 | -75 | 206 | 490 | 10 | 4 | 59 | 61 | 58 | -39 | -145 | 252 | 224 |
| Tax | -0 | -0 | -0 | 32 | 3 | 1 | 13 | 14 | 13 | -0 | -0 | 15 | 50 |
| Net profit | -479 | -75 | 206 | 458 | 8 | 3 | 46 | 48 | 45 | -39 | -145 | 237 | 175 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 335 | 398 | 603 | 1.194 | 945 | 1.095 | 959 | 1.038 | 833 | 749 | 767 | 898 | 978 |
| Equity | -399 | -474 | -268 | 190 | 198 | 200 | 247 | 295 | 339 | 301 | 155 | 392 | 567 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 734 | 872 | 871 | 1.004 | 747 | 894 | 712 | 744 | 493 | 448 | 611 | 505 | 411 |
| Total debt | 734 | 872 | 871 | 1.004 | 747 | 894 | 712 | 744 | 493 | 448 | 611 | 505 | 411 |
EBITDA margin
82.5%
This company
15.8%
Market median
+422% vs market
20132025
Equity ratio
58.0%
This company
38.2%
Market median
+52% vs market
20132025
Return on equity
30.8%
This company
18.4%
Market median
+67% vs market
20132025
Net profit margin
60.8%
This company
8.1%
Market median
+651% vs market
20132025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20132025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20132025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-02-19 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MC Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JOCOMO EQUIPAGE ApS | Company | 33.3% | 33.3% | 2013 |
PHARMAVIE A/S | Company | 33.3% | 33.3% | 2013 |
| Individual | 33.3% | 33.3% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MAW HOLDING ApS
NORDIC PHYTOTECH ApS Board members of NORDIC PHYTOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mogens Christensen Pedersen | Chief Executive Officer | 0 companies |
| Carsten Wærn | Chairman | 0 companies |
| Lars Erik Georg Lindmark | Board of Directors | 0 companies |